Hybrid Conferencee

International Conference on Blood Disorders and Therapeutics (ICBDT - 27)

5th - 6th January 2027 | Abu Dhabi, UAE
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 5–6 January 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 5 SDGs SDGs 3, 4, 9, 10 and 16
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

5 JAN 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Innovations in Hematology: Advances in Molecular Diagnostics
    34
    Track Overview

    This track will explore the latest advancements in molecular diagnostics for blood disorders, focusing on novel biomarkers and genetic testing techniques. Participants will discuss the implications of these innovations for early detection and personalized treatment strategies.

    Track 02
    Clinical Management of Blood Disorders: Best Practices and Challenges
    310
    Track Overview

    This session will address the current best practices in the clinical management of various blood disorders, including anemia, hemophilia, and leukemias. Experts will share insights on overcoming challenges in patient care and optimizing treatment outcomes.

    Track 03
    Transfusion Medicine: Safety, Efficacy, and Ethical Considerations
    316
    Track Overview

    This track will focus on the critical aspects of transfusion medicine, including safety protocols, efficacy of blood products, and ethical considerations in transfusion practices. Discussions will highlight recent guidelines and innovations aimed at improving patient safety.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Patient Monitoring and Management in Hematology
    39
    Track Overview

    This session will delve into the importance of patient monitoring in the management of blood disorders, emphasizing the role of technology and data analytics. Participants will examine case studies that illustrate effective monitoring strategies and their impact on patient outcomes.

    Track 05
    Emerging Therapeutics in Hematology: From Bench to Bedside
    39
    Track Overview

    This track will showcase cutting-edge research on emerging therapeutics for blood disorders, including novel drug development and gene therapies. Researchers will present their findings and discuss the translational potential of these therapies in clinical settings.

    Track 06
    Laboratory Techniques in Hematology: Innovations and Applications
    39
    Track Overview

    This session will highlight innovative laboratory techniques used in the diagnosis and management of blood disorders. Participants will explore the application of advanced technologies such as flow cytometry, mass spectrometry, and next-generation sequencing.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
View Day 02 Schedule →
Day 02

Keynote, Technical Sessions & Awards

6 JAN 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Clinical Trials in Hematology: Design, Challenges, and Future Directions
    39
    Track Overview

    This track will focus on the design and execution of clinical trials in the field of hematology, addressing common challenges faced by researchers. Discussions will include regulatory considerations, patient recruitment strategies, and the future landscape of clinical research.

    Track 08
    Understanding Disease Mechanisms in Blood Disorders
    34
    Track Overview

    This session will investigate the underlying mechanisms of various blood disorders, including genetic, environmental, and immunological factors. Experts will present their research on how these mechanisms influence disease progression and treatment responses.

    Track 09
    Pediatric Hematology: Unique Challenges and Therapeutic Approaches
    310
    Track Overview

    This track will address the unique challenges faced in the diagnosis and treatment of blood disorders in pediatric populations. Participants will discuss age-specific therapeutic approaches and the importance of multidisciplinary care in improving outcomes.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Integrative Approaches in Hematology: Combining Traditional and Modern Therapies
    310
    Track Overview

    This session will explore integrative approaches that combine traditional and modern therapeutic strategies for managing blood disorders. Discussions will focus on the efficacy and safety of complementary therapies in conjunction with conventional treatments.

    Track 11
    Global Perspectives on Hematology: Access and Equity in Care
    310
    Track Overview

    This track will examine global disparities in access to hematology care and the impact on patient outcomes. Experts will discuss strategies to improve equity in care delivery and the role of international collaborations in addressing these challenges.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
← Back to Day 01 Schedule
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure 10 Reduced Inequalities 16 Peace, Justice and Strong Institutions

Be Part of ICBDT-27

Submit your research or complete your conference registration.

Submit Abstract / Paper Complete Registration
Copyrights © . All Rights Reserved. Terms & Conditions